Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Apr 17;16(4):e58461.
doi: 10.7759/cureus.58461. eCollection 2024 Apr.

A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia

Affiliations
Case Reports

A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia

Haremaru Kubo et al. Cureus. .

Abstract

Acromegaly is a rare disorder characterized by excessive production of growth hormone (GH) from a pituitary tumor, typically leading to elevated glucose levels due to increased insulin resistance; hypoglycemia is rare. However, the long-term effect of excess GH on the peripheral organs is still unclear. Here we present a 69-year-old man evaluated for the cause of a hypoglycemic episode. He was underweight (body mass index: 17.3 kg/m2) with sarcopenia, which potentially contributed to his hypoglycemia. Notably, he exhibited progressed proliferative diabetic retinopathy compared to other microvascular complications, leading to further endocrinological investigation. As a result, he was diagnosed with acromegaly showing elevated GH and insulin-like growth factor-1 (IGF-1) with a pituitary tumor. Opting against transsphenoidal surgery (TSS), the patient was treated with a somatostatin analog (SSA), achieving normalized IGF-1 levels with a monthly 120 mg lanreotide injection. In this case, acromegaly could lead to sarcopenia from GH-derived gluconeogenesis in the peripheral organs such as the reduction of muscle leading to reduced glucose reserves. Acromegaly in the elderly may present atypicality. Clinicians should be vigilant for unique manifestations such as advanced diabetic retinopathy, even in elderly patients with hypoglycemia.

Keywords: acromegaly; diabetic retinopathy; hypoglycemia; insulin autoimmune disease; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Representative abdominal CT images of sarcopenia
Demonstrable axial CT images at the third lumbar vertebra region with highlighted skeletal muscles. The image was obtained from LightSpeed VCT Vision (GE Healthcare, Princeton, NJ, USA) and analyzed with Ziostation2 (Ziosoft, Tokyo, Japan). CT, computed tomography
Figure 2
Figure 2. An image of diabetic retinopathy in the right eye
Fundus photography of the present case was shown. Laser photocoagulation for proliferative diabetic retinopathy was repeated many times previously.
Figure 3
Figure 3. Images of acromegalic phenotypes
The phenotype led to suspicion of acromegaly. The facial features were prominent brow ridges (a), macroglossia, and thickened nose (b).
Figure 4
Figure 4. Images of the pituitary tumor
Non-contrast coronal and sagittal T2- (a and b) and T1-weighted (c and d) pituitary images with MRI are shown. White arrows indicate a mass. MRI, magnetic resonance imaging
Figure 5
Figure 5. Treatment time-course of the present case
Laboratory data and treatment time-course of the present case are shown. HbA1c, hemoglobin A1c; IGF-1, insulin-like growth factor-1; SD, standard deviation

Similar articles

References

    1. A consensus statement on acromegaly therapeutic outcomes. Melmed S, Bronstein MD, Chanson P, et al. Nat Rev Endocrinol. 2018;14:552–561. - PMC - PubMed
    1. A Pituitary Society update to acromegaly management guidelines. Fleseriu M, Biller BM, Freda PU, et al. Pituitary. 2021;24:1–13. - PMC - PubMed
    1. Clinical presentation and management of acromegaly in elderly patients. Ceccato F, Barbot M, Lizzul L, et al. Hormones (Athens) 2021;20:143–150. - PMC - PubMed
    1. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. Giustina A, Barkan A, Beckers A, et al. J Clin Endocrinol Metab. 2020;105:0–46. - PubMed
    1. Secondary diabetes mellitus in acromegaly. Moustaki M, Paschou SA, Xekouki P, et al. Endocrine. 2023;81:1–15. - PMC - PubMed

Publication types

LinkOut - more resources